Clinical trial · Interventional
Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer
Interactive Cancer Communication System (ICCS) in Lung Cancer: Evaluating Survival Benefits. Center of Excellence in Cancer Communication Research: Using Technology to Enhance Cancer Communication and Improve Clinical Outcomes
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will examine the potential for an Interactive Cancer Communication System (ICCS) to impact not only psychosocial outcomes such as quality of life but also length of survival in an advanced stage lung cancer population. Two hypotheses will be tested: the Comprehensive Health Enhancement Support System- Lung Cancer (CHESS- LC) will significantly improve patient quality of life and length of overall survival as compared to a usual care control group.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer, Stage IIIb or IV | Malignant Lung Neoplasm | CURATED_EXACT | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CHESS website for lung cancer patient + internet access if needed | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- CHESS with Clinician Report + Internet access
- description
- An Internet-based system, Comprehensive Health Enhancement Support System for Lung Cancer(CHESS-LC) integrates over 14 services to provide tailored cancer information, support, and interactive tools.
- interventionNames
- Other: CHESS website for lung cancer patient + internet access if needed
- type
- ACTIVE_COMPARATOR
- label
- Usual care with Internet access
- description
- Control group patients will be given a list of URLs for 10-high quality lung cancer-related sites
- interventionNames
- Other: CHESS website for lung cancer patient + internet access if needed
Primary outcomes (2)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * All patients must be diagnosed with non-small cell lung cancer (Stage IIIA non surgical, IIIB or IV) * All patients must be within 12 months of their primary lung cancer diagnosis or metastatic or recurrence disease. * All patients must be at least 18 years of age, * All patients must have an ECOG Performance Status rating of level 0, 1 or 2. * If patients have brain metastases, they must be stable * All patients must be under the care of a clinician who has consented to participate in the study. * All patients must be able to speak and read English (educational attainment of at least 6th grade). * All patients will be invited to have a caregiver also participate in the study, however this is not required.
References
Publications (0)
Data not yet available